Olivier Houille

Title: Innovator Spotlight: Olivier Houille

Introduction

Olivier Houille is a notable inventor based in Mulhouse, France, recognized for his contribution to medical science through innovative pharmaceutical compounds. With a focus on developing treatments for serious health conditions, his work aims to address vital issues related to platelet aggregation and thrombosis.

Latest Patents

Olivier holds a significant patent for "Pyrimidine derivatives and their use as P2Y12 receptor antagonists." This invention pertains to 4-aminocarbonyl-pyrimidine derivatives that serve as effective antagonists for the P2Y12 receptor. Such antagonists are crucial in the treatment, prevention, and management of a range of diseases associated with peripheral vascular, visceral, hepatic, renal, cardiovascular, and cerebrovascular conditions in both humans and other mammals.

Career Highlights

Currently, Olivier is associated with Actelion Pharmaceuticals Ltd., a company renowned for its dedication to innovative pharmaceutical solutions. His work at Actelion has played a pivotal role in advancing treatments for vascular diseases, showcasing his skills and commitment as a leading inventor in the pharmaceutical field.

Collaborations

Throughout his career, Olivier has collaborated with esteemed colleagues, including Eva Caroff and Heinz Fretz. These partnerships have enriched his research and development efforts, fostering a collaborative environment that enhances innovation and contributes to the progress of medical science.

Conclusion

Olivier Houille’s innovations and patents reflect his dedication to improving health outcomes through targeted therapies. His contributions to the field of pharmaceuticals exemplify the important role inventors play in shaping solutions for critical health challenges. As he continues his work, the potential for further advancements in the treatment of complex diseases remains promising.